VF
ORKA

Virtu Financial’s Oruka Therapeutics ORKA Stock Holding History

Virtu Financial’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$805K Buy
+8,456
New +$563K 0.03% 370
2022
Q4 		– Sell
-1,185
Closed -$29K – 2230
2022
Q3 		$29K Buy
+1,185
New +$33.5K ﹤0.01% 1329
2022
Q2 		– Sell
-1,990
Closed -$55K – 2169
2022
Q1 		$55K Buy
+1,990
New +$49.3K ﹤0.01% 1109
2021
Q2 		– Sell
-1,388
Closed -$61K – 2159
2021
Q1 		$61K Sell
1,388
-665
-32% -$34.9K ﹤0.01% 1411
2020
Q4 		$99K Buy
+2,053
New +$102K 0.01% 1056
2018
Q4 		– Sell
-464
Closed -$57K – 2057
2018
Q3 		$57K Buy
464
+306
+194% +$39.5K ﹤0.01% 1283
2018
Q2 		$19K Sell
158
-157
-50% -$18.4K ﹤0.01% 1868
2018
Q1 		$34K Buy
315
+206
+189% +$55.3K ﹤0.01% 1769
2017
Q4 		$32K Buy
109
+28
+35% +$8.11K ﹤0.01% 2148
2017
Q3 		$20K Buy
+81
New +$28.8K ﹤0.01% 2352

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Virtu Financial's ORKA Position: Q2 2026 in Review

Virtu Financial opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 8,456 shares worth $805K. The stake represents 0.03% of the portfolio and ranks #370 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ORKA as recently as Q3 2022.

Virtu Financial first reported a position in ORKA in Q3 2017 and has held it in 10 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Virtu Financial held 8,456 shares of Oruka Therapeutics worth $805K as of Q2 2026.
  • Oruka Therapeutics was a new Virtu Financial position in Q2 2026.
  • Oruka Therapeutics made up 0.03% of Virtu Financial's portfolio in Q2 2026, its #370 holding.
  • Virtu Financial first reported a position in Oruka Therapeutics in Q3 2017 and has held it in 10 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.